Cédric Cleyrat
Executive Director, Head of Cell Therapy BioEngineering & Technology Innovation, Bristol Myers Squibb
Cédric Cleyrat is listed as Executive Director, Head of Cell Therapy BioEngineering & Technology Innovation, Bristol Myers Squibb. Cédric is scheduled to speak at Advanced Therapies Week 2027 on 20 January 2027.
Compiled from published conference agendas; not yet confirmed by Cédric. Is this you? Claim this profile.
About
Cédric Cleyrat is a cellular and molecular biologist with deep expertise in protein signaling, genome engineering, and cell therapy technology innovation and development. At Bristol Myers Squibb, he leads BioEngineering & Technology Innovation, driving advances in cellular engineering, delivery systems, and process technology for next-generation cell therapies for both ex vivo (autologous and allogeneic) and in vivo non-viral applications.
Upcoming
Advanced Therapies Week 2027 19 January 2027 – 21 January 2027
- Pharma roundtable Speaker · 20 January 2027
- Plenary: Plotting a course to sustainable future success for the cell & gene therapy industry Speaker · 20 January 2027
Spoke alongside
People who have shared a session with Cédric at events on B2DB.
- Nelly Viseux VP Cell Therapies Development, Manufacturing Supply & Quality · Regeneron Pharmaceuticals 2 shared sessions
- Sven Kili Partner · Saisei Ventures 1 shared session
- Gina Jiang Managing Director · Hong Kong Institute of Biotechnology 1 shared session
- Peter He Co-Founder & Chief Scientific Officer · OriCell Therapeutics 1 shared session
- Samar Mohanty President & CSO · Nanoscope Therapeutics 1 shared session
- Steven Oh Director, Office of Cellular Therapy and Human Tissue, Office of Therapeutic Products, CBER · US Food & Drug Administration 1 shared session
- Yoshiaki Maruyama Director, Office of Cellular and Tissue-based Products · Pharmaceuticals and Medical Devices Agency (PMDA), Japan 1 shared session